Protean BioDiagnostics has collaborated with Nucleai to create a new Artificial Intelligence based product, HistoAI, for improving the efficiency and accuracy of Prostate Cancer pathology diagnosis. The AI powered Protean BioDiagnostics service will assist urologists and pathologists by analyzing digital images of whole slide scans of prostate core biopsies to rapidly identify and grade areas of prostatic carcinoma reducing the risk of diagnostic error.

Read More